In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.
--------
Question: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Section Commission to Advise on 
Reforming Elections Act''.

SEC. 2. ESTABLISHMENT OF SELECT COMMISSION TO ADVISE ON REFORMING 
              ELECTIONS.

    There is established a commission to be known as the ``Select 
Commission to Advise on Reforming Elections'' (referred to in this Act 
as the ``Commission''). The purposes of the Commission are to study the 
laws relating to the financing of campaigns for elections for Federal 
office and to report and recommend legislation to reform those laws.

SEC. 3. MEMBERSHIP OF COMMISSION.

    (a) Appointment.--The Commission shall be composed of 12 members 
appointed not later than 60 days after the date of the enactment of 
this Act by the President, of whom--
            (1) Three members shall be appointed from among a list of 
        nominees submitted by the majority leader of the House of 
        Representatives;
            (2) Three members shall be appointed from among a list of 
        nominees submitted by the majority leader of the Senate;
            (3) Two members shall be appointed from among a list of 
        nominees submitted by the minority leader of the House of 
        Representatives;
            (4) Two members shall be appointed from among a list of 
        nominees submitted by the minority leader of the Senate; and
            (5) Two members shall be appointed from individuals meeting 
        such criteria as the President may apply.
    (b) Chair.--The members of the Commission shall select two members 
to serve as co-chairs of the Commission.
    (c) Terms.--The members of the Commission shall serve for the life 
of the Commission.
    (d) Vacancies.--A vacancy in the Commission shall be filled in the 
manner in which the original appointment was made.

SEC. 4. POWERS OF COMMISSION.

    (a) Hearings.--The Commission may, for the purpose of carrying out 
this Act, hold hearings, sit and act at times and places, take 
testimony, and receive evidence as the Commission considers 
appropriate.
    (b) Quorum.--Five members of the Commission shall constitute a 
quorum, but a lesser number may hold hearings.

SEC. 5. ADMINISTRATIVE PROVISIONS.

    (a) Pay and Travel Expenses of Members.--(1) Each member of the 
Commission, other than the co-chairs, shall be paid at a rate equal to 
the daily equivalent of the annual rate of basic pay payable for level 
IV of the Executive Schedule under section 5315 of title 5, United 
States Code, for each day (including travel time) during which the 
member is engaged in the actual performance of duties vested in the 
Commission. Each co-chair shall be paid for each day referred to in the 
preceding sentence at a rate equal to the daily equivalent of the 
annual rate of basic pay payable for level III of the Executive 
Schedule under section 5314 of title 5, United States Code.
    (2) Members of the Commission shall receive travel expenses, 
including per diem in lieu of subsistence, in accordance with sections 
5702 and 5703 of title 5, United States Code.
    (b) Staff Director.--The Commission shall, without regard to 
section 5311(b) of title 5, United States Code, appoint a staff 
director, who shall be paid at the rate of basic pay payable for level 
IV of the Executive Schedule under section 5315 of title 5, United 
States Code.
    (c) Staff of Commission; Services.--
            (1) In general.--Subject to such rules as may be adopted by 
        the Commission, the staff director of the Commission, without 
        regard to the provisions of title 5, United States Code, 
        governing appointments in the competitive service and without 
        regard to the provisions of chapter 51 and subchapter III of 
        chapter 53 of that title relating to classifications and 
        General Schedule pay rates, and subject to the approval of the 
Commission, may appoint such personnel as the staff director considers 
necessary, except that an individual so appointed may not receive pay 
in excess of the maximum annual rate of basic pay payable for grade GS-
15 of the General Schedule under section 5332 of title 5, United States 
Code.
            (2) Temporary and intermittent services.--Subject to the 
        approval of the Commission, the staff director of the 
        Commission may procure temporary and intermittent services to 
        the same extent as is authorized by section 3109(b) of title 5, 
        United States Code.

SEC. 6. REPORT AND RECOMMENDATIONS FOR CHANGES IN LAW.

    (a) Report.--Not later than 180 days after the appointment of its 
members, the Commission shall submit to the President, the Speaker and 
minority leader of the House of Representatives, and the majority and 
minority leaders of the Senate a report of the activities of the 
Commission.
    (b) Recommendations for Changes in Campaign Finance Laws.--
            (1) In general.--Subject to paragraph (2), the Commission 
        shall submit to the President, the Speaker and minority leader 
        of the House of Representatives, and the majority and minority 
        leaders of the Senate any recommendations for changes in the 
        laws (including regulations) governing the conducting and 
        financing of Federal campaigns (including any changes in the 
        rules of the Senate or the House of Representatives) to which 
        seven or more members of the Commission may agree--
                    (A) by including such recommendations in the report 
                submitted under subsection (a); or
                    (B) with the approval of a majority of its members, 
                by submitting a supplemental report containing such 
                recommendations not later than 180 days after 
                submitting the report under subsection (a).
            (2) Final deadline.--The Commission may not submit 
        recommendations under this subsection after July 15, 1998.
    (c) Dissenting Views.--The Commission shall include in the report 
submitted under subsection (a) and in any recommendations submitted 
under subsection (b) any dissenting or minority views of its members, 
including recommendations for changes in law which were proposed by any 
member and to which seven or more members did not agree.

SEC. 7. EXPEDITED CONGRESSIONAL CONSIDERATION OF LEGISLATION 
              IMPLEMENTING RECOMMENDATIONS.

    (a) Preparation of Legislation.--If the Commission submits any 
recommendation for changes in the laws under section 6(b), those 
members concurring in the recommendation shall include with the 
recommendation legislation to implement the recommendation.
    (b) Expedited Congressional Consideration of Legislation.--
            (1) In general.--If any legislation is introduced the 
        substance of which implements a recommendation of the 
        Commission submitted under section 6(b), subject to paragraph 
        (2), the provisions of section 2908 (other than subsection (a)) 
        of the Defense Base Closure and Realignment Act of 1990 shall 
        apply to the consideration of the legislation in the same 
        manner as such provisions apply to a joint resolution described 
        in section 2908(a) of such Act.
            (2) Special rules.--For purposes of applying paragraph (1) 
        with respect to such provisions, the following rules shall 
        apply:
                    (A) Any reference to the Committee on Armed 
                Services of the House of Representatives shall be 
                deemed a reference to the Committee on House Oversight 
                of the House of Representatives and any reference to 
                the Committee on Armed Services of the Senate shall be 
                deemed a reference to the Committee on Rules and 
                Administration of the Senate.
                    (B) Any reference to the date on which the 
                President transmits a report shall be deemed a 
                reference to the date on which the recommendation 
                involved is submitted under section 6(b).

SEC. 8. TERMINATION.

    The Commission shall cease to exist 90 days after the later of--
            (1) the date of the submission of its report under section 
        6(a); or
            (2) the date of the submission of its recommendations under 
        section 6(b).

Answer: Select Commission to Advise on Reforming Elections Act - Establishes the Select Commission to Advise on Reforming Elections to study the laws relating to the financing of campaigns for Federal elections and to report and recommend legislation to reform those laws. 
(Sec. 6) Requires the Commission to submit a report to the President, the Speaker and minority leader of the House of Representatives, and the majority and minority leaders of the Senate on its activities.  Directs the Commission, as specified, to submit to the President, the Speaker and minority leader of the House of Representatives, and the majority and minority leaders of the Senate, any recommendations for changes in campaign finance laws to which seven or more Commission members may agree.  Prohibits the submission of recommendations by the Commission after July 15, 1998. 
(Sec. 7) Requires that when the Commission submits any recommendation for changes in campaign finance laws, those Commission members concurring in the recommendation shall include legislation to implement the recommendation.  Provides for expedited congressional consideration of any legislation introduced which implements a recommendation of the Commission. 
(Sec. 8) Terminates the Commission after the later of:  (1) the submission of its report; or (2) the submission of its recommendations.


Question: SECTION 1. BAN ON DISCLOSURE OF MEDICAL QUALITY ASSURANCE INFORMATION.

    Subsection (a) of section 5705 of title 38, United States Code, is 
amended--
            (1) by inserting ``(1)'' after ``(a)''; and
            (2) by adding at the end the following:
    ``(2)(A) Except as provided in subsection (b), no part of any 
medical quality assurance record or document described in subsection 
(a)(1) may be subject to discovery or admitted into evidence in any 
judicial or administrative proceeding.
    ``(B) An individual who reviews or creates medical quality 
assurance records or documents for the Department or who participates 
in any proceeding that reviews or creates such records or documents may 
not be permitted or required to testify in any judicial or 
administrative proceeding with respect to such records or documents or 
with respect to any finding, recommendation, evaluation, opinion, or 
action taken by such person in connection with such records or 
documents except as provided in this section.''.

SEC. 2. DISCLOSURE AUTHORITY.

    (a) Clarification of Coverage.--Subsection (b)(1) of section 5705 
of title 38, United States Code, is amended by striking out ``or 
document'' in the matter above subparagraph (A) and inserting in lieu 
thereof ``, document, or testimony''.
    (b) Disclosure for Professional Use.--Such subsection is further 
amended by adding at the end the following:
            ``(E) In an administrative or judicial proceeding commenced 
        by a criminal or civil law enforcement agency or 
        instrumentality referred to in subparagraph (C), but only 
        concerning the subject of such proceeding.
            ``(F) To a governmental board or agency or to a 
        professional health care society or organization, if such 
        record or document is needed by the board, agency, society, or 
        organization to issue a professional license or credential to 
        or to monitor the compliance with professional standards of any 
        health care provider who is or was an employee of the 
        Department.
            ``(G) To a hospital, medical center, or other institution 
        that provides health care services, if such record or document 
        is needed by the institution to assess the professional 
        qualifications of any health care provider who is or was an 
        employee of the Department and who has applied for or been 
        granted authority or employment to provide health care services 
        in or on behalf of such institution.
            ``(H) To an administrative or judicial proceeding commenced 
        by a present or former Department health care provider 
        concerning the termination, suspension or limitation of the 
        clinical privileges of such health care provider, or concerning 
        any adverse action involving such health care provider, but 
        only to the extent that such records or documents relate to the 
        clinical conduct or performance of the individual who has 
        commenced the action.''.
    (c) Removal of Identities.--Subsection (b)(2) of such section is 
amended by striking out ``if disclosure'' and all that follows through 
``personal privacy'' and inserting in lieu thereof ``subparagraphs 
(1)(A) and (1)(B) of this subsection''.

SEC. 3. LIMITATION ON DISCLOSURE.

    Paragraph (3) of section 5705(b) of title 38, United States Code, 
is amended to read as follows:
    ``(3) A person or entity having possession of, or access to, 
information, records, or documents, or testimony relating thereto, that 
is subject to the provisions of this section may not disclose such 
information, records, or documents, or any testimony relating thereto, 
in any manner or for any purpose except for a purpose as provided in 
this subsection. No person or entity to whom a record or document has 
been disclosed under this subsection shall make further disclosure of 
such record or document except for a purpose provided in this 
subsection.''.

SEC. 4. ACCESS TO RECORDS.

    Subsection (b) of section 5705 of title 38, United States Code, is 
amended by adding at the end the following:
    ``(7) Medical quality assurance records and documents described in 
subsection (a) which are subject to section 552a of title 5 may not be 
disclosed in accordance with that section except to the extent that 
such disclosure is also authorized under this section.
    ``(8) Medical quality assurance records or documents described in 
subsection (a) which are also subject to section 552a of title 5--
            ``(A) shall not be subject to the access provisions of such 
        section 552a to the extent that such access would reveal the 
        identities of participants in the quality assurance process 
        which generated the records or documents; and
            ``(B) are not subject to the amendment provisions of such 
        section 552a.
    ``(9) Medical quality assurance records and documents described in 
subsection (a) may not be made available to any person under section 
552 of title 5.''.

SEC. 5. REGULATIONS.

    Subsection (d)(2) of section 5705 of title 38, United States Code, 
is amended by striking out ``specified in'' and inserting in lieu 
thereof ``accomplished in accordance with''.

Answer: Prohibits Department of Veterans Affairs medical quality assurance records from being subject to discovery or admitted into evidence in any judicial or administrative proceeding.  Prohibits an individual who participates in the production of such records from being required to testify at such a proceeding. 
Allows testimony concerning such records (currently, only the records or documents themselves) to be disclosed to Federal agencies for certain limited purposes (licensing, accreditation).  Specifies additional uses for which such information may be disclosed. 
Includes information and testimony related to such records within certain disclosure limitation provisions. 
Prohibits the disclosure of such records by the Department as public information to the extent that such disclosure would reveal the identities of the participants in the quality assurance process which generated the records or documents.


Question: SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Preserving Access to Affordable 
Drugs Act of 2005''.

SEC. 2. ELIMINATION OF DISCRIMINATORY TREATMENT OF EMPLOYER PLANS.

    (a) Elimination of True Out-Of-Pocket Limitation.--Section 1860D-
2(b)(4)(C) of the Social Security Act (42 U.S.C. 1395w-102(b)(4)(C)) is 
amended to read as follows:
                    ``(C) Application.--In applying subparagraph (A), 
                incurred costs shall only include costs incurred with 
                respect to covered part D drugs for the annual 
                deductible described in paragraph (1), for cost-sharing 
                described in paragraph (2), and for amounts for which 
                benefits are not provided because of the application of 
                the initial coverage limit described in paragraph 
                (3).''.
    (b) Equalization of Subsidies.--Notwithstanding any other provision 
of law, the Secretary of Health and Human Services shall provide for 
such increase in the special subsidy payment amounts under section 
1860D-22(a)(3) of the Social Security Act (42 U.S.C. 1395w-132(a)(3)) 
as may be appropriate to provide for payments in the aggregate 
equivalent to the payments that would have been made under section 
1860D-15 of such Act if the individuals were not enrolled in a 
qualified retiree prescription drug plan. In making such computation, 
the Secretary shall not take into account the application of the 
amendments made by section 1202 of the Medicare Prescription Drug, 
Improvement, and Modernization Act of 2003 (Public Law 108-173; 117 
Stat. 2480).

SEC. 3. DIRECT SUBSIDY FOR CERTAIN STATE PHARMACEUTICAL ASSISTANCE 
              PROGRAMS.

    Part D of title XVIII of the Social Security Act (42 U.S.C. 1395w-
101 et seq.) is amended by inserting after section 1860D-23 the 
following new section:

``direct subsidies for certain state pharmaceutical assistance programs

    ``Sec. 1860D-23A. (a) Direct Subsidy.--
            ``(1) In general.--The Secretary shall provide for the 
        payment to a State offering a State pharmaceutical assistance 
        program described in section 1860D-23(b)(1) for each individual 
        who is eligible for, but not enrolled in, a prescription drug 
        plan or MA-PD plan under this part, and who is enrolled in such 
        program for each month for which such individual is so 
        enrolled.
            ``(2) Amount of payment.-- The amount of the payment under 
        paragraph (1) shall be an amount equal to the special subsidy 
        payment amount determined under section 1860D-22(a)(3) for a 
        qualifying covered retiree for a coverage year enrolled with 
        the sponsor of a qualified retiree prescription drug plan.
    ``(b) Additional Subsidy.--
            ``(1) In general.--The Secretary shall provide for the 
        payment to a State offering a State pharmaceutical assistance 
        program described in section 1860D-23(b)(1) for each applicable 
        low-income individual enrolled in the program for each month 
        for which such individual is so enrolled.
            ``(2) Amount of payment.--
                    ``(A) In general.--The amount of the payment under 
                paragraph (1) shall be the amount the Secretary 
                estimates would have been made to a prescription drug 
                plan or MA-PD plan under section 1860D-14 with respect 
                to the applicable low-income individual if such 
                individual was enrolled in such a plan.
                    ``(B) Maximum payments.--In no case may the amount 
                of the payment determined under subparagraph (A) with 
                respect to an applicable low-income individual exceed, 
                as estimated by the Secretary, the average amount paid 
                in a year under section 1860D-14 on behalf of a subsidy 
                eligible individual (as defined in section 1860D-
                14(a)(3)(A)) with income that is the same as the income 
                of the applicable low-income individual.
            ``(3) Applicable low-income individual.--For purposes of 
        this subsection, the term `applicable low-income individual' 
        means an individual who--
                    ``(A) is eligible for, but not enrolled in, a 
                prescription drug plan or MA-PD plan under this part, 
                and who is enrolled in a State pharmaceutical 
                assistance program described in section 1860D-23(b)(1); 
                and
                    ``(B) would be a subsidy eligible individual (as 
                defined in section 1860D-14(a)(3)(A)) if the individual 
                were enrolled in such a plan.
    ``(c) Payment Methods.--
            ``(1) In general.--Payments under this section shall be 
        based on such a method as the Secretary determines. The 
        Secretary may establish a payment method by which interim 
        payments of amounts under this section are made during a year 
        based on the Secretary's best estimate of amounts that will be 
        payable after obtaining all of the information.
            ``(2) Source of payments.--Payments under this section 
        shall be made from the Medicare Prescription Drug Account.
    ``(d) Construction.--Nothing in this section, section 1860D-23, or 
section 1860D-24 shall be construed as requiring a prescription drug 
plan or MA-PD plan to coordinate coverage provided under such plan with 
coverage provided under a State pharmaceutical assistance program 
described in section 1860D-23(b)(1) that is operated by a State which 
receives a payment under this section.''.

SEC. 4. FACILITATION OF COORDINATION.

    Section 1860D-24(c)(1) of the Social Security Act (42 U.S.C. 1395w-
134(c)(1)) is amended by striking ``all methods of operation'' and 
inserting ``its own methods of operation, except that a PDP sponsor or 
MA organization may not require a State Pharmaceutical Assistance 
Program or an RX plan described in subsection (b) to apply such tools 
when coordinating benefits''.

SEC. 5. ALLOWING MEDICAID WRAP.

    Section 1935 of the Social Security Act (42 U.S.C. 1396u-5) is 
amended by striking subsection (d).

SEC. 6. REPEAL OF COMPARATIVE COST ADJUSTMENT PROGRAM.

    Subtitle E of title II of of the Medicare Prescription Drug, 
Improvement, and Modernization Act of 2003 (Public Law 108-173) is 
repealed and any provisions of law amended by such subtitle are 
restored as if such subtitle had not been enacted.

SEC. 7. PROVISION OF WRAP-AROUND PRESCRIPTION DRUG COVERAGE THROUGH 
              MEDIGAP.

    Section 1882(v) of the Social Security Act (42 U.S.C. 1395ss(v)) is 
amended as follows:
            (1) In paragraph (1)(A), by inserting ``, other than such a 
        policy that provides wrap-around prescription drug coverage 
        included within a range of such coverage approved under 
        subparagraph (D)(ii),'' after ``paragraph (6)(A))''.
            (2) Add at the end of paragraph (1) the following new 
        subparagraph:
                    ``(D) Wrap-around prescription drug coverage.--
                            ``(i) In general.--Notwithstanding any 
                        other provision of this subsection, a medigap 
                        Rx policy that provides wrap-around 
                        prescription drug coverage included within a 
                        range of such coverage approved by the 
                        Secretary under clause (ii) may be offered to 
                        part D enrollees.
                            ``(ii) Development of standards.--The 
                        Secretary shall approve a range of wrap-around 
                        prescription drug coverage that may be offered 
                        under this subparagraph to part D enrollees.''.

SEC. 8. EFFECTIVE DATE.

    The amendments made by this Act, and the repeal made by section 6, 
shall take effect as if included in the enactment of the Medicare 
Prescription Drug, Improvement, and Modernization Act of 2003 (Public 
Law 108-173).

Answer:
Preserving Access to Affordable Drugs Act of 2005 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to: (1) allow employer contributions on drug costs to count towards the annual out-of-pocket limit; and (2) provide for direct subsidies for certain State pharmaceutical assistance programs.

Directs the Secretary of Health and Human Services to ensure that employer-based plans receive the same subsidization as the Medicare prescription drug plans.

Amends SSA title XIX (Medicaid) to ensure that States can provide supplemental Medicaid prescription drug coverage to complement the Medicare drug benefit for seniors who are dually eligible for Medicare and Medicaid.

Repeals the comparative cost adjustment program under Medicare.

Amends SSA title XVIII part D to allow the provision of wrap-around prescription drug coverage through Medigap.